CIK 0001527599 · Non-accelerated filer<br>Smaller reporting company
SYNLOGIC, INC.
Sign in to watch- Ticker
- SYBX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261824804
- Phone
- 617-659-2802
- Business address
- PO BOX 30, WINCHESTER, MA, 01890
- Former names
- Mirna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 94 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | Heffernan Michael Thomas Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-22 | Hurter Patricia N. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-22 | Barrett Peter Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-04-03 | Awad Antoine Chief Operating Officer | Sale | −6,438 | $0.58 | $4K | 74,732 |
| 2023-04-03 | Brennan Aoife See Remarks | Sale 10b5-1 | −19,042 | $0.58 | $11K | 256,301 |
| 2023-04-03 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Sale | −2,553 | $0.58 | $1K | 46,947 |
| 2023-01-03 | Barrett Peter Director | Grant or award · Stock Option (right to buy) | +156,130 | 156,130 | ||
| 2023-01-03 | Hurter Patricia N. Director | Grant or award · Stock Option (right to buy) | +91,954 | 91,954 | ||
| 2022-06-09 | Mathers Edward T Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Leschly Nick Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Barrett Peter Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Hurter Patricia N. Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Heffernan Michael Thomas Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Shea Richard P Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Burgess Michael F. Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-06-09 | Kelly-Croswell Lisa Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2022-05-24 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Purchase | +9,500 | $1.12 | $11K | 39,500 |
| 2022-04-04 | Brennan Aoife See Remarks | Sale | −8,894 | $2.45 | $22K | 275,343 |
| 2022-04-04 | Awad Antoine Chief Operating Officer | Sale | −2,650 | $2.45 | $6K | 81,170 |
| 2022-03-03 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Grant or award | +30,000 | 30,000 |
Page 4 of 8 · 152 trades